Summary
29 / 100 · Bulios Score
What speaks for it
- Revenue grew by 32% a year over the last 3 years.
- Analysts expect revenue to grow by 41% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 11.7 years of operating profit.
- It missed profit estimates 7 times in the last 8 quarters.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (MXN)
Diluted EPS (MXN)
- Analyst estimate
Revenue grew by 32% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 41%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 3.38B $.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $56.67 is 7.3% below today's price. 86% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.